Funding of the New Animal Drug Application (NADA) and Abbreviated New Animal Drug Application (ANADA) approval process

To help ensure adequate availability of veterinary drugs, the AVMA supports increased congressional funding of the FDA Center for Veterinary Medicine for the NADA and ANADA approval processes indexed to keep pace with cost increases.

The AVMA supports user fees for new animal drug applications and abbreviated new animal drug applications only if such fees are directed toward expediting the review and approval processes for animal drug products.